Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2026-04-05 @ 6:02 AM
Study NCT ID:
NCT02153632
Status:
TERMINATED
Last Update Posted:
2022-02-16
First Post:
2014-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Sponsor:
Adamas Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OS320-3006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None